Medigene AG (FRA:MDG1) Volatility: 154.13% (As of Jun. 28, 2026)


FRA:MDG1 Medigene AG FRA:MDG1
12 GF Score
Price €0.02
View Full Analysis

What is Medigene AG Volatility?

Medigene AG FRA:MDG1 -10.20% 12 Volatility is 154.13% as of Jun. 28, 2026. GuruFocus rates FRA:MDG1 with a GF Score™ of 12/100.

Volatility is a statistical measure of the dispersion of returns for a given security or market index, it shows how the price swings around its mean. The volatility here is measured as the annualized standard deviation between monthly returns from the security over the past year. In most cases, the higher the volatility, the riskier the security.

As of today (2026-06-28), Medigene AG's Volatility is 154.13%.

Medigene AG  (FRA:MDG1) Volatility Explanation

Volatility is a statistical measure of the dispersion of returns for a given security or market index. It’s often measured as standard deviation or variance of historical returns over a certain period. The volatility here is measured as the annualized standard deviation between monthly returns from the security over the past year.

Volatility reflects the uncertainty or risk of a security’s value. Generally speaking, a higher volatility suggests a higher risk, because it implies a wider fluctuation around average price. This means the price of the security can change dramatically in either direction within a short period. Conversely, a lower volatility means that the security's price is more steady, which suggests a lower risk.

Another measurement of relative volatility is Beta. Beta is a measure of systematic risk of a security or a portfolio in comparison to the market as a whole. Beta is usually compared to 1. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Medigene AG Volatility Related Terms

FRA:MDG1 vs VRTX, REGN, ALNY: Volatility Comparison

For the Biotechnology subindustry, Medigene AG's Volatility, along with its competitors' market caps and Volatility data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medigene AG Volatility vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medigene AG's Volatility distribution charts can be found below:

* The bar in red indicates where Medigene AG's Volatility falls into.


FRA:MDG1
12GF Score
Medigene AG FRA:MDG1
Volatility is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medigene AG  (FRA:MDG1) Volatility Calculation

The annualized volatility is calculated as following:

σA=σM * √12
=√ 1/(n-1) ∑(Ri - R')^2 * √12

Where: σM is the monthly volatility, n is the number of months in the period, Ri is the security's historical monthly returns and R' is the arithmetic mean of monthly returns.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Volatility →
What does a Volatility of 154.13% mean?
Medigene AG (FRA:MDG1) has a Volatility of 154.13% as of Jun. 28, 2026. Volatility is measured as the annualized standard deviation between monthly returns from the security over the past year. View historical data on Medigene AG and its competitors.
Is Medigene AG's Volatility too high?
Medigene AG's current Volatility is 154.13%. Overall, Medigene AG has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Medigene AG's Volatility compare to VRTX and REGN?
Medigene AG's Volatility of 154.13% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Volatility for a Biotechnology company?
A good Volatility depends on the Biotechnology industry context. However, Volatility should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Volatility mean?
A high Volatility can signal that a stock is expensive relative to its fundamentals. Volatility is measured as the annualized standard deviation between monthly returns from the security over the past year. View historical data on Medigene AG and its competitors. Medigene AG's current Volatility is 154.13%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medigene AG stock overvalued right now?
Medigene AG (FRA:MDG1) has a current Volatility of 154.13%. The current Volatility is 154.13%. Medigene AG's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Volatility calculated?
Volatility is calculated from a company's financial statements. For Medigene AG (FRA:MDG1), the current Volatility is 154.13% as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medigene AG Business Description

Address Lochhamer Strasse 11, Martinsried, Planegg, BY, DEU, 82152
Medigene AG is an immuno-oncology biotechnology company. focused on developing differentiated T Cell Receptor engineered T cell (TCR-T) therapies for the treatment of multiple solid tumor indications with a high unmet medical need. The operating segments of the organization are Immunotherapies and Other products. Immunotherapies consist of T-cell receptor-based adoptive T-cell therapy and DC vaccines. The group operates in the United States, Germany, and Asia, of which the majority of the revenue is derived from operations in Germany.
12GF Score

Get the complete analysis for FRA:MDG1

Volatility is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.02
Price